1. Field of the Invention
Embodiments of the present invention are directed to systems and methods for the treatment of body lumens. More particularly, the present invention relates to catheter systems for treatment and/or diagnosis of vessels, including those relating to angioplasty treatment.
2. Description of the Related Art
Stents are implantable prosthesis used to maintain and/or reinforce vascular and endoluminal ducts in order to treat and/or prevent a variety of medical conditions. Typical uses include maintaining and supporting coronary arteries after they are opened and unclogged, such as through an angioplasty operation. A stent is typically deployed in an unexpanded or crimped state using a catheter and, after being properly positioned within a vessel, is then expanded into its final shape (such as with an expandable balloon incorporated into the catheter).
As a foreign object inserted into a vessel, a stent can potentially impede the flow of blood. This effect can cause or exacerbate undesired growth of tissue on and around the stent, potentially leading to complications including thrombosis and restenosis. The likelihood of such problems is significantly increased as a result of a stent's non-conformity with a vessel's walls when expanded. Thus, stent systems are generally designed to minimize the impedance of a vessel by including a minimal level of strut material, by being flexible in order to conform to a vessel's walls. Typical materials for stent struts include stainless steel, cobalt-chromium, and nitinol.
Many stenting procedures are further challenged when targeting occlusions around vessel bifurcations or other highly curved tracts. Some methods attempt to bend stents to conform to the tract. Such a procedure can be difficult with a traditional balloon catheter because a fully expanded balloon will typically form a straight, highly inflexible tubular body that will resist compliance to the vessel's natural shape. This can lead to a stent being non-conformant with the vessel or bifurcation area and can cause undesired damage to the vessel's walls and further impede blood flow.
Rather than attempt to bend a single stent to conform to a tenuously curved area, multiple overlapping stents have been placed about the area in order to avoid some of the above described challenges. However, the use of multiple stents, e.g. in a “kissing stent” bifurcation, can lengthen and complicate a procedure, adding additional risk and expense. The overlapping portions of the stents may also unnecessarily add obstructive stent material, potentially interfering with blood flow and increasing the likelihood of complications such as restonosis.
Some stent bifurcation systems are designed with stents having “trap doors” or other openings in order to avoid blocking vessel branch openings or for allowing passage of subsequent stents. Such systems are proposed in, for example, US patent publication No. 2004/0176837 A1, incorporated herein by reference in its entirety. These systems, however, can typically require expensive and/or complex deployment components or procedures. Because positioning of these systems generally requires an accurate rotational component and because traditional positioning methods (e.g. fluoroscopy) generally do not provide for accurate rotational placement within a vessel, improved apparatus and methods are needed for placement of these types of systems.
Other catheter systems include semi-compliant angioplasty balloons which can provide moderate compliance in some lumen expansion applications. These balloons are only generally appropriate for peripheral vessel applications, however, and do not provide sufficient force to sufficiently expand and/or stent certain vessels including, for example, some coronary vessels. Moreover, these balloons may not provide optimal compliance in circumstances of high vessel curvature.
Other alternative stenting systems include the use of self-expanding stents such as nitinol-based stents, which can be expanded to a “memorized” diameter without requiring the use of a balloon for full expansion. However, self-expanding stents may also not provide sufficient radial force to properly retain the shape of some vessel walls such as in, for example, some coronary vessels.
Solutions are thus needed which allow for a balloon-expanded stent to be placed conformingly in bifurcated vessels or other tenuously shaped areas while retaining sufficient radial force within high-pressure vessels, and while minimizing the expense and risks of the procedure.
Aspects of the invention provide systems, procedures and apparatus for analyzing and treating body lumens, including highly curved vessels and vessel branches such as in, for example, a stent bifurcation procedure. In an embodiment of the invention, a system is provided including a catheter having a lumen-expanding balloon disposed about the catheter's distal end. In an embodiment of the invention, the balloon is deployed with a stent having a predetermined opening adapted to be highly conformant with a branch vessel opening. In another embodiment of the invention, the balloon is a pre-shaped balloon adapted to substantially conform with the curvature of a vessel.
The balloon catheter is integrated with one or more waveguides comprising at least one transmission output and at least one transmission input. The system can be programmed to gather information from the waveguides so as to direct the positioning, including rotational and/or longitudinal positioning, of the balloon and/or stent across a bifurcation and/or a highly curved vessel area. In an embodiment of the invention, the one or more transmission outputs and inputs are positioned to transmit and receive light about a section of the periphery of the shaped balloon. In an embodiment of the invention, the system is configured for providing information for positioning a pre-shaped balloon to conform with a vessel area upon expansion.
In an embodiment of the invention, waveguides are connected to a light source for distributing light radiation and connected to a detector for collecting light radiation about the balloon. The system can include one or more devices such as an intensity meter, a spectrometer, and/or an interferometer for analyzing the light radiation collected from outside the balloon wall. The one or more devices can be used to calculate and monitor the depth of blood between the balloon wall and the vessel wall and for positioning the balloon for optimal deployment.
The system can be configured to provide analysis through various wavelength ranges of radiation including, for example, visible and near-infrared radiation. An embodiment of the invention is configured to transmit and receive across wavelengths between about 200 and 2500 nanometers and, in a further embodiment of the invention, configured to transmit and receive across wavelengths of between about 300 and 700 nanometers. The system can be configured to transmit and receive across one or more single or multiple wavelength bands. In an embodiment of the invention, a range of one or more transmission wavelengths is distinct from a range of one or more detected wavelengths as in, for example, a fluorescence spectroscopy system. An embodiment of the invention includes transmitting through blood across one or more wavelengths centered about an excitation wavelength of, for example, about 450 nanometers and detecting a responsive emission across one or more wavelengths centered about, for example, 520 nanometers.
In an embodiment of the invention, a system is configured for estimating the distance between a section of the balloon's wall and a vessel wall in order to locate a branch vessel's opening with respect to the catheter.
In an embodiment of the invention, a stent with an expanded or “trap-door” opening, for example, can be positioned on a balloon to be subsequently deployed and positioned with respect to a branch vessel opening. The “trap-door” or expanded strut opening aligned with a branch vessel can be used, for example, to subsequently place an additional stent through the opening such as in a bifurcation procedure. In an embodiment of the invention, the information can be used to subsequently place a pre-shaped balloon across a highly curved area such that the pre-shaped balloon, in its expanded state, would align with the curvature of the vessel area. In an embodiment of the invention, the information about a vessel wall's proximity to the catheter can be used to determine the direction of curvature of the vessel area with respect to the catheter in order to place and conform a pre-shaped balloon within the vessel upon expansion.
In an aspect of the invention, a system is provided for treating a body lumen including a catheter having a flexible conduit that is elongated along a longitudinal axis and suitable for insertion into a body lumen, the conduit having a proximal end and a distal end. The system includes one or more waveguides integrated with the flexible conduit, the one or more waveguides constructed and arranged to deliver and collect radiation concentrated along a predetermined radial axis of the conduit, the predetermined radial axis of the conduit substantially aligned with respect to at least one therapy delivery component of the catheter. The system also includes at least one radiation source connected to a transmission input of the one or more waveguides integrated with the flexible conduit and at least one optical detector connected to a transmission output of the one or more waveguides integrated with the flexible conduit.
In an embodiment, the system includes an expandable balloon about the distal end of the conduit, wherein the at least one therapy delivery component includes a feature of an angioplasty catheter.
In an embodiment, the feature of the angioplasty catheter includes a stent. In an embodiment, the feature of said angioplasty catheter includes a predetermined opening within said stent.
In an embodiment, the feature of the angioplasty catheter includes an expandable balloon. In an embodiment, the feature of the angioplasty catheter includes a predetermined preformed portion of the expandable balloon.
In an embodiment, the system includes a controller programmed to process data from the optical detector so as to direct an alignment of the at least one therapy delivery component.
In an embodiment of the invention, a system includes an analysis subsystem programmed and configured for determining a relative measure of blood depth outward along the predetermined radial axis from the conduit. In an embodiment of the invention, a radiation source is configured to supply radiation of one or more wavelengths within the range of about 250 to 2500 nanometers. In an embodiment of the invention, the radiation source is configured to supply radiation of one or more wavelengths within the range of about 400 and 1400 nanometers. In an embodiment of the invention, the radiation source is configured to supply radiation of one or more wavelengths within the range of about 400 and 700 nanometers.
In an embodiment of the invention, a radiation source is configured and arranged to supply radiation of one or more predetermined wavelengths and wherein the optical detector is configured and arranged to selectively detect radiation distinct from wavelengths supplied by the radiation source. In an embodiment of the invention, the system includes a dichroic filter arranged to separate radiation of wavelengths selected for delivery and radiation of wavelengths selected for collection and detection.
In an embodiment of the invention, a radiation source and optical detector are configured and arranged to induce and detect fluorescence. In an embodiment of the invention, the radiation source is configured to supply radiation including wavelengths of less than about 500 nanometers and the optical detector is configured and arranged to selectively detect radiation of greater than about 500 nanometers. In an embodiment of the invention, the radiation source is configured to supply radiation including a wavelength of 450 nanometers and wherein the optical detector is configured and arranged to selectively detect radiation including a wavelength of 520 nanometers.
In an embodiment of the invention, the system includes an optical arrangement for supplying and collecting radiation through a combined delivery output and collection input.
In an embodiment of the invention, an optical detector is connected to a spectrometer. In an embodiment of the invention, the spectrometer is configured to perform spectroscopy selected from the group of spectroscopy methods including fluorescence, light scatter, optical coherence reflectometry, optical coherence tomography, speckle, correlometry, Raman, and diffuse reflectance spectroscopy.
In an embodiment of the invention, a radiation source and an optical detector are connected to an interferometer.
In an embodiment of the invention, the system includes an intensity meter for measuring the level of signal associated with a characteristic of bodily blood or tissue. In an embodiment of the invention, the characteristic of bodily blood or tissue includes the depth of blood across an area of interest.
In an embodiment of the invention, the system includes a control and display device. In an embodiment of the system, the control and display device includes an indicator of blood-depth signal intensity to an operator. In an embodiment of the invention, the control and display device includes a mechanism for controlling the rotational position of the flexible conduit. In an embodiment of the invention, the control and display device is hand-held.
In an aspect of the invention, a catheter for placement within a body lumen is provided. The catheter includes a flexible conduit that is elongated along a longitudinal axis, the flexible conduit having a proximal end and a distal end. The catheter further includes at least one therapy delivery component and one or more waveguides positioned along the flexible conduit. The one or more waveguides are constructed and arranged to deliver and collect radiation concentrated about a predetermined radial axis of the conduit, the predetermined radial axis substantially aligned with respect to the at least one therapy delivery component.
In an embodiment of the invention, the therapy delivery component comprises a predetermined opening of a stent. In an embodiment of the invention, the predetermined opening is formed to substantially conform with an opening of a vessel bifurcation so as to reduce the impedance of blood flow. In an embodiment of the invention, the predetermined opening is positioned between the longitudinal ends of the stent body. In an embodiment of the invention, the predetermined opening forms an extended circumferential gap. In an embodiment of the invention, the predetermined opening is positioned at a longitudinal end of the stent body. In an embodiment of the invention, the predetermined opening forms a beveled end out of the stent body.
In an embodiment of the invention, an at least one waveguide consists of a single waveguide constructed and arranged to simultaneously deliver and collect radiation.
In an embodiment of the invention, an at least one waveguide includes at least one delivery waveguide and at least one separate collection waveguide.
In an embodiment of the invention, the catheter includes an expandable balloon about the distal end of the conduit in which a feature of the expandable balloon is a therapy delivery component. In an embodiment of the invention, a therapy delivery component of the balloon includes a pre-formed area of the balloon configured to dilate an adjacent opening of a vessel bifurcation. In an embodiment of the invention, this pre-formed area forms a bulbous augmentation of the balloon when expanded. In an embodiment of the invention, a therapy delivery component of the balloon causes the balloon to bend along its longitudinal axis when expanded so as to improve conformance of the expanded balloon within the shape of a curved vessel.
In an aspect of the invention, a method for treatment of a body lumen is provided. The methods include the step of inserting into a body lumen a catheter including a flexible conduit having at least one therapy delivery component. The flexible conduit includes one or more waveguides positioned along the flexible conduit, the one or more waveguides constructed and arranged to deliver and collect radiation concentrated about a predetermined radial axis of the conduit, the predetermined circumferential position substantially aligned with respect to at least one therapeutic component. The method further includes the steps of maneuvering the conduit into a designated region of the body lumen designated for treatment and optimizing rotational alignment of the at least one therapeutic component for providing therapy within the body lumen. The step of optimizing rotational alignment includes repeating the steps of rotating the flexible conduit within the body lumen, measuring and analyzing optical signals collected through the one or more waveguides, and relating the analysis of the optical signals with an optimal rotational position. The method further includes a step of activating the therapeutic component.
In an embodiment of the invention, the designated region of the body designated for treatment includes a vessel bifurcation. In an embodiment of the invention, the at least one therapeutic component includes a stent with a predetermined opening. In an embodiment of the invention, the step of optimizing rotational alignment of the conduit optimizes alignment of the opening of the stent with the opening of the vessel bifurcation.
In an embodiment of the invention, the designated region of the body designated for treatment includes a vessel area highly curved along its longitudinal axis. In an embodiment of the invention, the at least one therapeutic component comprises an expandable balloon manufactured to become curved upon expansion so that it substantially conforms to the longitudinal curvature of the vessel area. In an embodiment of the invention, the step of optimizing rotational alignment of the conduit optimizes rotational orientation of the balloon to longitudinally conform with the highly curved vessel.
In an embodiment of the invention, an at least one therapeutic component comprises an expandable balloon having a pre-formed area configured to dilate an adjacent opening of a vessel bifurcation upon expansion. In an embodiment of the invention, the step of optimizing rotational alignment of the conduit optimizes rotational orientation of the balloon to align the pre-formed area with the adjacent opening.
In an embodiment of the invention, a step of measuring and analyzing optical signals comprises delivering and collecting radiation concentrated along a predetermined radial axis of the conduit. In an embodiment of the invention, the step of measuring and analyzing optical signals comprises measuring a signal associated with a blood depth spanning radially outward along the predetermined radial axis of the conduit. In an embodiment of the invention, the signals associated with a blood depth are analyzed at a plurality of catheter rotations to distinguish between a vessel bifurcation opening and a lack of an opening along the predetermined radial axis of the conduit. In an embodiment of the invention, the signals associated with a blood depth are analyzed at a plurality of catheter rotations to distinguish between a relatively convex shaped vessel wall and a relatively concave shaped vessel wall about the predetermined radial axis of the conduit.
In an embodiment of the invention, a step of activating the therapy delivery component comprises expanding a lumen expanding balloon.
In an embodiment of the invention, a step of measuring and analyzing optical signals comprises delivering radiation of wavelengths within the range of about 250 to 2500 nanometers. In an embodiment of the invention, the step of measuring and analyzing optical signals comprises delivering radiation of wavelengths within the range of about 400 to 1400 nanometers. In an embodiment of the invention, the step of measuring and analyzing optical signals comprises delivering radiation of wavelengths within the range of about 400 to 700 nanometers.
In an embodiment of the invention, a step of measuring and analyzing optical signals collected through the one or more waveguides comprises inducing and measuring fluorescence by delivering radiation of one or more wavelengths so as to induce fluorescence, and measuring the intensity of radiation generated from the fluorescence. In an embodiment of the invention, an at least one wavelength of the radiation measured from the fluorescence is distinct from the one or more wavelengths of the radiation delivered to induce fluorescence. In an embodiment of the invention, the one or more wavelengths of the radiation generated to induce fluorescence includes a wavelength of 450 nanometers and wherein the at least one wavelength of the radiation generated from the fluorescence includes a wavelength of 520 nanometers.
In an embodiment of the invention, a step of measuring and analyzing optical signals comprises performing spectroscopy selected from the group of spectroscopy methods consisting of fluorescence, light scatter, optical coherence reflectometry, optical coherence tomography, speckle, correlometry, Raman, and diffuse reflectance spectroscopy.
In an embodiment of the invention, a step of activating the therapeutic component comprises delivering therapeutic radiation to a targeted area.
In an embodiment of the invention, a step of longitudinally aligning the flexible conduit includes the steps of measuring and analyzing optical signals collected through the one or more waveguides, and relating the analysis of the optical signals with an optimal longitudinal position. In an embodiment of the invention, the step of longitudinally aligning the flexible conduit includes a plurality of steps of longitudinally moving the flexible conduit interspersed with a plurality of steps of measuring and analyzing optical signals collected through the one or more waveguides.
In an aspect of the invention, a method for treatment or analysis of a body lumen is provided. The method includes a step of inserting into a body lumen a catheter including a flexible conduit having at least one analysis or therapeutic component. The flexible conduit includes one or more waveguides positioned along the flexible conduit in which the one or more waveguides are constructed and arranged to deliver and collect radiation concentrated about a predetermined radial axis of the conduit and in which the predetermined radial axis is substantially aligned relative to at least one analysis component or therapy delivery component. The method further includes the steps of maneuvering the conduit into a designated region of the body lumen designated for analysis or treatment and optimizing positional alignment of the at least one analysis or therapeutic component within the body lumen. The step of optimizing positional alignment includes repeating the steps of moving the flexible conduit within the body lumen, measuring and analyzing optical signals collected through the one or more waveguides, and relating the analysis of the optical signals with an optimal position. The method further includes the step of activating the analysis component or therapy delivery component.
In an embodiment of the invention, a step of activating the at least one analysis or therapeutic component includes performing spectroscopy selected from the group of spectroscopy methods consisting of fluorescence, light scatter, optical coherence reflectometry, optical coherence tomography, speckle, correlometry, Raman, and diffuse reflectance spectroscopy.
In an embodiment of the invention, a step of optimizing positional alignment includes optimizing rotational alignment.
In an embodiment of the invention, a step of optimizing positional alignment includes optimizing longitudinal alignment.
The foregoing and other objects, features, and advantages of the invention will be apparent from the more particular description of preferred embodiments of the invention, as illustrated in the accompanying drawings in which like reference characters refer to the same parts throughout the different views. The drawings are not necessarily to scale, emphasis instead being placed upon illustrating the principles of the invention.
Referring to
The proximal end of the catheter 10 includes a section 110 through which fibers 60, a guidewire 27, and an inflation media supply line 52 are integrated. The proximate ends of fiber lines 60 are connected to the device 56. Device 56 can include a source and detector as described in additional detail in further embodiments included herein. A display 58 is provided for relaying information (e.g., the intensity of detected signals) to an operator of the device. Device 56 additionally includes a knob 54 for controlling the supply of inflation media to balloon 40.
Referring further to
Referring to
Section 50 of catheter 10 includes the distribution and collection ends, respectively, of one or more fibers such as, for example, source fiber 65 and collection fiber 67, which are fixed adjacent to catheter body 20 within balloon 40 so they can distribute and collect light about the outside of balloon 40. Balloon 40 is manufactured to be optically clear to the selected radiation and can be manufactured with various materials including, for example, nylon, polyethylene, or other translucent polymers. Stent 45 includes an expanded opening 55 through which a subsequent stent (e.g., see
Referring in particular to
In an embodiment of the invention, the separation distance 72 between the distal ends of fibers 65 and 67 and their numerical aperture are optimized with respect to the diameter of catheter 10 and the expected diameter of a vessel in which the catheter is deployed. Both separation distance 72 and numerical aperture will generally influence the direction and depth of signals traveling to and from the catheter. Numerical aperture and separation distance may also affect the breadth of the tissue surface area analyzed in each measurement, which should preferably be minimized for purposes of accurate positional determination. The diameter of fibers 65 and 67 should also be minimized (e.g. distribution fiber 65 is of less than about a 100 micron diameter and collection fiber 67 is of less than about a 200 microns diameter) so that the catheter can remain as flexible as possible. Optimum separation distances and numerical apertures can be characterized through tests of signals through anticipated depths of blood/tissue media. A larger numerical aperture will generally be required of a collection fiber in order to facilitate the loss of signal strength between transmission and collection. The separation distance is also be limited by the amount of power that surrounding tissue can safely withstand from a radiation source, which should generally be limited to a maximum of about 20 milliwatts.
Referring to
Referring to
Referring to
Referring to
Collected radiation, e.g. fluorescence radiation, may then travel along path 348 to filter 330. In an embodiment of the invention, filter 330 can be selected to be transmissive to a wavelength range of interest different from an excitation-inducing wavelength range, such as 30 to 100 nm longer than an excitation-inducing wavelength range. Radiation passing through filter 330 then travels along path 325 to a photo sensor 320 capable of measuring the intensity of the selected wavelength range. In an embodiment of the invention, the radiation wavelength range produced by source 345 is selected to cause an excitation of a different wavelength range within the targeted medium (i.e., blood). Fluorescence filters and other filters for separating wavelength ranges are available from a variety of commercial vendors including, for example, Semrock, Inc. of Rochester, N.Y.
In an embodiment of the invention, a source wavelength range can be between about 200 and about 2500 nanometers. In a further embodiment, a source wavelength range can be between about 300 and 1400 nanometers. In a further embodiment, a source wavelength range can be between about 400 and 700 nanometers. In an embodiment, an excitation-inducing wavelength of about 450 nanometers produces a fluorescence excitation emission wavelength in blood of about 520 nanometers. Source 345 can be a low-cost LED which is selected to provide a wavelength range between, for example, about 400 and 500 nanometers, concentrating energy at about 450 nanometers. Filter 330 can be selected, for example, to reflect radiation greater than about 500 nanometers including 520 nanometer radiation. Upon consideration of the present disclosure, various modified arrangements of filters, sources, and other optical components, optical paths, and wavelength ranges would be apparent to one of ordinary skill in the art.
A fluid supply line 355 and fiber 372 are integrated into a catheter sheath 380 leading to an expandable balloon assembly 360 (shown within a vessel area 30) such as in accordance with various embodiments of the present invention disclosed herein. An operator can, for example, rotate the distal end assembly 360 to various positions interspersed in between steps of performing optical analysis. Rotation of distal end assembly 360 and analysis of lumen area 30 can be performed in accordance with various embodiments of the invention including, for example, those disclosed in connection with
A signal processor 315 translates a reading from sensor 320 to a signal to be used with an I/O and/or display device 310 such as an intensity indicator 375, which can indicate to an operator the relative depth of blood of an area adjacent a pre-determined portion of the distal end of the catheter system 300. Intensity indicator 375 can be comprised of one or more LEDs, for example, in which the one or more of the LEDs indicate the level of depth via states of on or off and/or varying intensity. In another embodiment of the invention, an audio signal generator (not shown) is integrated into the system 305 to indicate depth via tones and/or volume. An inflation lever 350 controls the distribution of inflation media within a balloon of an expandable balloon assembly 360. A pressure indicator 365 displays the amount of pressure within the balloon. In an embodiment of the invention, an intensity lever and/or amplification control lever 354 is optionally included for purposes controlling and/or calibrating the sensitivity of indicator 375 such as by adjusting the intensity of source radiation from source 345 or the amplification level of the collected signal through photo-sensor 320. Calibrating sources/signals may be useful depending on the type and size of a targeted treatment area.
In an embodiment of the invention, catheter system 300 and layout 305 is manufactured for disposable cost-effective use. For example, the enclosure 307 can be molded of easily assembled plastic components including its movable parts such as, for example, balloon media supply knob 354, source intensity control knob 350, among other various parts. Media fluid pressure indicator can be of a common type used in other angioplasty catheters. Intensity indicator 375 can be a simple LED-type indicator calibrated to reflect a general relative intensity output from a signal processor such as processor 315. Various filters and other optical components of layout 305 can also be made of low-cost plastic parts such as, for example, filter 330 and focusing lens 340. Source 345 can be powered by a low-cost disposable/replaceable battery (not shown) housed in enclosure 307.
Referring to
Radiation is collected through the distal end of fiber 470 (integrated in the distal end 460 of catheter system 400) and transmitted through input connector 435. Collected radiation may then travel along a sample path 448 to a photo sensor 420. In an embodiment of the invention, an intensity inverter 425 inverts the signal received from sensor 420 in order to provide an absorbance signal to a signal processor 415 and to an I/O and/or display device 410 for supplying data to an operator or externally connected device. In an embodiment of the invention, absorbance data is used to provide diffuse-reflectance spectroscopic analysis of surrounding blood and tissue such as for calculating a measurement of the span of blood between a predetermined location on distal end 460 and a vessel wall.
An operator can rotate the distal end assembly 460 to various positions while providing analysis during a procedure such as in accordance with various embodiments of the invention (e.g.,
In an embodiment of the invention, source 445 is selected to provide a wavelength range which is substantially absorbed in a blood medium while being highly reflective off of a tissue wall. Such a range can include, for example, wavelengths within a range of between about 200 and 2500 nanometers (from about the ultra-violet through about the near infrared spectrum). In a further embodiment of the invention, a wavelength range of between about 400 and 1400 nanometers is used. Referring to
In an embodiment, the analysis system can be made to discriminate between relevant data such as for determining the geometry of a vessel (e.g. data from targeted blood and tissue) and other data not relevant such as, for example, data relating to the features of a balloon, stent, and/or coatings of a stent. Such features may include, for example, spectral characteristics and/or “shadows” associated with compoents such as a stent, balloon, or guidewire. These features pose a risk of interfering with received radiation, but this risk can be mitigated or eliminated by programming in a data analysis procedure via the spectroscopic analysis system that compensates for such features. Techniques for discriminating data from potentially interfering features are described in, for example, U.S. Pat. No. 6,615,062 by Ryan et al., the entire contents of which are herein incorporated by reference.
Referring to
Assuming a vessel size of greater than about 2 mm, the gap between the peripheral edge of the catheter and a vessel wall (including across bifurcations) would be approximately 0.5 mm or greater. Thus, in another embodiment of the invention, absorption within a range of wavelengths between about 400 and 1400 nm (including, for example, peaks at about 456, 546, 580, and 966 nm) can generally be measured for deployment in vessels of greater than about 2 mm. The additional peak at about 966 nm for larger diameter vessels will be generally associated with that of water (H2O) absorption. Components, including sources, detectors, and fiber optics are available for measuring backscattered absorption spectra within these ranges from various commercial vendors including, for example, Ocean Optics Inc. of Dunedin, Fla.
While a system such as catheter system 400 would generally be of greater cost and complexity than a simpler system such as catheter system 300 of
Referring to
Inside of catheter body 520 is a guidewire sheath 525, through which a guidewire 527 can travel and initially direct the positioning of catheter 500 such as in a percutaneous transluminal angioplasty procedure.
Referring to
Referring further to
Referring to
Referring to
Referring in particular
Referring to
Referring further to
In another embodiment of the invention,
The predicted distribution and collection radiation paths from various embodiments of the catheters disclosed herein can be aligned relative to various features of catheters including therapy delivery components such as, for example, stent strut openings, beveled stent ends, longitudinal stent openings, curvatures of expanded pre-shaped balloons, laser delivery components, tissue extraction components, optical and/or sonic analysis components, and/or other analysis and treatment components.
Embodiments of optical arrangements can incorporate or be combined with other optical arrangements and catheter probe systems such as, for example, those described in previously referenced co-pending application Ryan '500. For example, in an embodiment of the invention, the analysis system provided by Ryan '500 can be combined with embodiments of the present invention in order to perform more detailed and extensive analysis of specific areas circumferentially or longitudinally disposed with respect to the end of a catheter.
It will be understood by those with knowledge in related fields that uses of alternate or varied forms or materials and modifications to the methods disclosed are apparent. This disclosure is intended to cover these and other variations, uses, or other departures from the specific embodiments as come within the art to which the invention pertains.
This application claims the benefit of U.S. Patent Application No. 60/945,481, filed on Jun. 21, 2007, U.S. Patent Application No. 61/019,626, filed on Jan. 8, 2008, and U.S. Patent Application No. 61/025,514, filed on Feb. 1, 2008, the contents of each of which is incorporated herein by reference in its entirety. This application is related to U.S. patent application Ser. No. 11/537,258, filed on Sep. 29, 2006, published as Patent Application Publication No. 2007/0078500 A1, and U.S. patent application Ser. No. 11/834,096, filed on Aug. 6, 2007, the entire contents of each of which is herein incorporated by reference.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/US08/67669 | 6/20/2008 | WO | 00 | 12/4/2009 |
Number | Date | Country | |
---|---|---|---|
60945481 | Jun 2007 | US | |
61019626 | Jan 2008 | US | |
61025514 | Feb 2008 | US |